Clinical Trials in Crystal Lake, United States
Locations / Crystal Lake, United States
Delta Trials hosts 147 clinical trials conducted in Crystal Lake, United States, making it a notable site of clinical research activity. These trials covering 477 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 6 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Crystal Lake.
147
Total Trials
477
Conditions
6
Terminated since 2020
Browse by condition (477 total)
- Diabetes mellitus, type 2 16 trialsAll Diabetes mellitus, type 2 trials
- Diabetes 10 trialsAll Diabetes trials
- Stage iv lung cancer ajcc v8 8 trialsAll Stage iv lung cancer ajcc v8 trials
- All Anatomic stage ii breast cancer ajcc v8 trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- Diabetes mellitus, type 1 6 trialsAll Diabetes mellitus, type 1 trials
- Metastatic malignant solid neoplasm 6 trialsAll Metastatic malignant solid neoplasm trials
- Stage iiib lung cancer ajcc v8 5 trialsAll Stage iiib lung cancer ajcc v8 trials
- Invasive breast carcinoma 5 trialsAll Invasive breast carcinoma trials
- Type 1 diabetes mellitus 5 trialsAll Type 1 diabetes mellitus trials
- Prostate adenocarcinoma 5 trialsAll Prostate adenocarcinoma trials
- Lung non-small cell carcinoma 4 trialsAll Lung non-small cell carcinoma trials
- Breast cancer 4 trialsAll Breast cancer trials
- All Anatomic stage i breast cancer ajcc v8 trials
- Recurrent ovarian carcinoma 4 trialsAll Recurrent ovarian carcinoma trials
- All Recurrent lung non-small cell carcinoma trials
- Advanced malignant solid neoplasm 3 trialsAll Advanced malignant solid neoplasm trials
- Melanoma 3 trialsAll Melanoma trials
- Her2-negative breast carcinoma 3 trialsAll Her2-negative breast carcinoma trials
- All Prognostic stage ii breast cancer ajcc v8 trials